Circumcision and HIV Risk: Protective Effect
Male circumcision reduces heterosexual HIV acquisition risk by 50–60%.
Evidence
- Three RCTs (South Africa, Kenya, Uganda): 51–60% reduction in HIV incidence over 24 months.
- WHO/UNAIDS recommend voluntary medical male circumcision (VMMC) in high-prevalence settings.
- Mechanism: Removal of foreskin (rich in Langerhans cells, target for HIV); keratinization of glans; reduced microtears; improved hygiene.
Important Caveats
- Partial protection only; not a substitute for condoms, PrEP, treatment as prevention.
- Benefit primarily for insertive vaginal sex; limited data for MSM, receptive anal sex.
- No protection against other STIs (may reduce HSV-2, HPV).
- Procedure risks: bleeding, infection, pain, rare complications (0.2–0.6% severe).
- Ethical: Infant vs. adult autonomy; cultural/religious dimensions.
Comprehensive prevention = VMMC + condoms + PrEP + ART for partners + STI screening + behavioral counseling.
HIV & AIDS - Related Articles
- HIV Antibody Counselor: Role, Responsibilities & Support
- Benefits of Technological Aids: Efficiency, Accuracy, Accessibility, and Innovation
- Understanding Acute HIV Infection: Symptoms & Testing
- Top 3 HIV Prevention Strategies: Condoms, PrEP, and PEP
- HIV Seroconversion: Symptoms, Timeline & What to Do
- Comprehensive Therapies for HIV/AIDS: Antiretroviral, Herbal, and Supportive Treatments
- HIV Transmission & Circumcision: Risks and Prevention
